Glyphic Biotechnologies
PrivateLast Round
Series A
Feb 16, 2024
Total Funding Raised
$39.99M
Company Overview
Glyphic Biotechnologies is a biotechnology company that develops a single-molecule, massively parallel, de novo next-generation protein sequencing platform to enable novel therapeutics and diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Glyphic Biotechnologies Comparables
Compare Glyphic Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Encodia | 87% | |
| Genopore | 86% | |
| Prisma Biotechnology | 84% | |
Glyphic Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 16, 2024 | ||||
| Grant | Sep 15, 2023 | ||||
| Grant | Sep 6, 2022 | ||||
| Seed | Jul 8, 2021 |
Glyphic Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Zeon Ventures | Series A |
| NIH RADx | Grant |
| Cantos Ventures | Seed |
| FoundersX Ventures | Series A, Seed |
| ARTIS Ventures | Series A, Seed |
| Osage University Partners | Series A, Seed |
| LongeVC | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 16, 2024
$33M round completed.
- Sep 15, 2023
$359K grant received from NIH RADx.
Glyphic Biotechnologies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Glyphic Biotechnologies's valuation, stock price, and market status.